RecruitingNot ApplicableNCT06202105
Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer
Comparison of Laparoscopic Versus Open Total Gastrectomy for Locally Advanced Gastric Cancer: a Prospective Randomized Control Trial
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Enrollment
210 participants
Start Date
Aug 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Evidence of implementation of laparoscopic total gastrectomy (LTG) for locally advanced gastric cancer (GC) remains inadequate. This study aimed to compare short- and mid-term outcomes of LTG versus open total gastrectomy (OTG) for cT2-4a GC.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria6
- Pathologic finding by gastric endoscopy: confirmed gastric adenocarcinoma
- Age: 18 - 80 year old
- Tumor required total gastrectomy for radical treatment
- Preoperative cancer stage (CT scan stage): cT2-4aNanyM0
- ASA score: ≤ 3
- Informed consent patients (explanation about our clinical trials is provided to the patients or patrons, if patient is not available)
Exclusion Criteria4
- Concurrent cancer or patient who was treated due to other cancer before the patient was diagnosed gastric cancer
- Bulky lymph node andd/or Para-aortic lymph node metastasis
- Combined esophagectomy due to invading to the esophagus
- Pregnant patient
Interventions
PROCEDURELaparoscopic gastrectomy
Gastrectomy with laparoscopic approach
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06202105
Related Trials
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
NCT072774391 location
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
NCT051871821 location
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria
NCT074811102 locations
Study for AZD4360 in Participants With Advanced Solid Tumours
NCT0692192817 locations
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT0570222944 locations